Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormonal treatment for deep endometriosis
RBR-8fjx2jpPhase 2Recruiting
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in deep infiltrating endometriosis (DIE) and endometriosis comparing Oral dienogest with Levonorgestrel intrauterine device (2 arms). Started Dec 2020; status: recruiting.
02
Drugs
dienogestavatrombopag
03
Conditions
deep infiltrating endometriosis (DIE)endometriosis
Beyond the preview
Go deeper on RBR-8fjx2jp.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8fjx2jp.